During the 1st webinar participants were introduced to the updates in TB preventive treatment; WHO approach to the people-centered delivery of TB prevention, diagnosis, treatment, and care during the COVID-19 pandemic; current evidence and lessons learned on COVID-19 and TB; as well as the challenges to reach the EndTB strategy goals.
The agenda of the 2nd webinar included the key changes in the treatment of drug-resistant TB, highlights from the forthcoming WHO consolidated TB guidelines, supporting activities of WHO EURO on laboratory diagnosis and MDR-TB during and beyond COVID-19 pandemic, as well as the evidence to date on trials of treatment for M/XDR-TB.
- To build the capacity of TB specialists in TB clinical management
- To introduce the updates from the WHO consolidated guidelines on TB prevention, diagnosis, treatment, and care.
- To scale-up approaches in delivering a people-centered model of TB care
- To learn about innovations, digital solutions, and latest evidence and recommendations in management of TB
- Series of online lectures, interactive discussions, case studies, live demonstrations, group work sessions, participant’s presentations, sharing opinions and experiences of participants;
- Virtual site visits to the TB facilities of TB and Lung Diseases Center of Riga East University hospital (virtual insights of the National TB Reference Laboratory and TB outpatient department, including video - observed treatment, organization of TB patient care in primary health care settings, infection control, as well as the online drug-resistant TB clinical consilium.
- The faculty of WHO CC Latvia, involving more than 20 TB experts, clinicians, scientists, researchers, nurses, and public health staff.
- In addition, WHO CC Latvia regularly cooperates with international organizations and projects to engage in training activities experts from the field and provide high-level, evidence-based up-to-date training
Objectives of the 3rd webinar were to discuss the priority actions to strengthen the Baltic countries TB control programs and help countries to improve national responses to the COVID-19 pandemic; to build the capacity of TB clinicians in the provision of anti-TB treatment, in line with the latest WHO guidelines and evidence and to introduce the best practices in the use of video supported TB treatment solutions in support of TB patients.